Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03218137 · ClinicalTrials.gov registry record · Phase 4
Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
A Phase 4 study of Premature Ventricular Contraction (PVC), sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03218137 is a Phase 4 study of Premature Ventricular Contraction (PVC) that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03218137, a Phase 4 study of Premature Ventricular Contraction (PVC), is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and/or verapamil to learn if their arrhythmias are inducible similarly to sustained ventricular tachycardia.
Conditions Studied
Interventions
- DRUG Adenosine
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03218137
The ClinicalTrials.gov registry entry for NCT03218137 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Premature Ventricular Contraction (PVC) appearing as the primary indexed condition, and to 1 intervention - of which Adenosine is the first listed.
NCT03218137 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03218137 about?
NCT03218137 is a clinical study titled "Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions". Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and...
What is the current status of trial NCT03218137?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2017-02-13. Estimated completion is 2025-12-31.
What conditions does trial NCT03218137 study?
This clinical trial studies the following conditions: Premature Ventricular Contraction (PVC).
What interventions are being tested in trial NCT03218137?
The interventions under investigation include: Adenosine (DRUG).
Who is sponsoring clinical trial NCT03218137?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03218137 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Ventricular Contraction (PVC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.